vigabatrin has been researched along with Kidney Diseases in 1 studies
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The plasma VGB concentration-time data were analyzed by mixed-effects modeling to estimate population pharmacokinetic parameters and to identify any significant demographic covariates." | 2.67 | A comparison of population and standard two-stage pharmacokinetic analyses of vigabatrin data. ( Bhargava, VO; Hutcheson, SJ; Wei, G; Weir, SJ; Yu, DK, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, DK | 1 |
| Hutcheson, SJ | 1 |
| Wei, G | 1 |
| Bhargava, VO | 1 |
| Weir, SJ | 1 |
1 trial available for vigabatrin and Kidney Diseases
| Article | Year |
|---|---|
A comparison of population and standard two-stage pharmacokinetic analyses of vigabatrin data.
Topics: 4-Aminobutyrate Transaminase; Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Cohort | 1994 |